Social network analysis methods for exploring SARS-CoV-2 contact tracing data

Abstract

Background Contact tracing data of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is used to estimate basic epidemiological parameters. Contact tracing data could also be potentially used for assessing the heterogeneity of transmission at the individual patient level. Characterization of individuals based on different levels of infectiousness could better inform the contact tracing interventions at field levels. Methods Standard social network analysis methods used for exploring infectious disease transmission dynamics was employed to analyze contact tracing data of 1959 diagnosed SARS-CoV-2 patients from a large state of India. Relational network data set with diagnosed patients as “nodes” and their epidemiological contact as “edges” was created. Directed network perspective was utilized in which directionality of infection emanated from a “source patient” towards a “target patient”. Network measures of “ degree centrality” and “betweenness centrality” were calculated to identify influential patients in the transmission of infection. Components analysis was conducted to identify patients connected as sub- groups. Descriptive statistics was used to summarise network measures and percentile ranks were used to categorize influencers. Results Out-degree centrality measures identified that of the total 1959 patients, 11.27% (221) patients have acted as a source of infection to 40.19% (787) other patients. Among these source patients, 0.65% (12) patients had a higher out-degree centrality (> = 10) and have collectively infected 37.61% (296 of 787), secondary patients. Betweenness centrality measures highlighted that 7.50% (93) patients had a non-zero betweenness (range 0.5 to 135) and thus have bridged the transmission between other patients. Network component analysis identified nineteen connected components comprising of influential patient’s which have overall accounted for 26.95% of total patients (1959) and 68.74% of epidemiological contacts in the network. Conclusions Social network analysis method for SARS-CoV-2 contact tracing data would be of use in measuring individual patient level variations in disease transmission. The network metrics identified individual patients and patient components who have disproportionately contributed to transmission. The network measures and graphical tools could complement the existing contact tracing indicators and could help improve the contact tracing activities.

Synergistic networks of COVID-19’s top papers

“…Dehghanbanadaki et al (2020), based on Scopus data, concluded that BMJ (Clinical Research Edition) had published the most articles in the field of COVID-19. Nagarajan et al (2020) also believe that SNA helped health practitioners and their activities in investigating the SARS-COV-2. Also, Laksham et al (2020) claimed that reputable Open Access journals had played an important role in publishing the results of Coronavirus research.…”

Why Re-Invent the Wheel? Social Network Approaches Can Be Used to Mitigate SARS-CoV-2 Related Disparities in Latinx Seasonal Farmworkers

“…Because contact tracing is a time intensive endeavor for HCPs, social network mapping can assist HCPs with having a conversation about a patient’s social circle, who needs to be contacted to limit further spread. Social network mapping can also identify social network members who should be contacted to disseminate SARS-CoV-2 information [ 25 ]. These methods have been successfully employed in previous projects that sought to increase HIV prevention activities, such as condom use and HIV prevention knowledge [ 26 ].…”

The role of age in the spreading of COVID-19 across a social network in Bucharest

“…Or, briefly, to how social relationships are organized within society [12,13]. In effect, ideas and statistical models from the network science [14] have already been applied to various topics related to the COVID-19 pandemic, such as the global and local spread of the virus [1,15,16], the exploration of SARS-COV-2 contact tracing data [6,17,18], the assessment of vaccination strategies [19,20], the analysis of vaccine patents [21], the evaluation of distancing strategies [22], etc.…”